- Radiology imaging specialists IMEXHS will be providing its ‘Hiruko’ software across 10 healthcare institutions in Puerto Rico as part of a service deal
- Rad One PSC clinics have signed on to use Hiruko as part of a five year contract, roughly worth AU$2.37 million
- Hiruko uses a fully-web based voice recognition platform to enhance the health imaging process – with no installation needed
- Rad One estimates over 7000 clinical uses of Hiruko at its institutions across a seven-month study program of the software – starting in the near future
Healthcare imaging IMEXHS has signed a five year contract worth roughly AU$2.37 million.
The company has inked a new ‘software as a service’ relationship with Puerto Rican healthcarers Rad One PSC. Rad One has over 20 years experience in servicing patients in emergency rooms and imaging centres across 10 institutions.
IMEXHS’ core business is its platform ‘Hiruko’ platform service. Hiruko is a suite software that enhances clinical use of radiology hardware and services. The system is completed cloud based, needs no install and is vendor neutral.
Hiruko also uses a fully web-based voice recognition system. IMEXHS’ platform is aimed at cutting costs for users and increasing productivity.
Today’s deal is part of the company’s process in breaking into the U.S. healthcare market. Company Chief Sales Officer Andres Vanegas echoed this goal.
“We are looking forward to gaining valuable insights into US-style workflows through this project, where we will have the opportunity to accelerate the localisation of our suite of capabilities tailored for US market requirements,” said Andres
IMEXHS’ soft launch strategy into the American market is planned within this year and next year. A localisation trial is outlined alongside invoicing users from paying contracts next year.
“We have agreed with Rad One a 7 month trial for the localisation period, whilst IMEXHS US FDA 510(k) certification is pending,” he said.
Nine Rad One institutions are expected to integrate the IMEXHS software over the seven months. Each site contract represents a value of US$165,000. Monthly, Rad One estimate around 7000 clinical studies to use the IMEXHS software.
Share prices in IME are unchanged today, sitting at 5.1 cents a piece. The company’s market cap is currently valued at $47.2 million.